Presentation TCT 2024 TCT 214: Patient-Specific Computer Simulation to Predict Transcatheter Heart Valve Eccentricity in Bicuspid Aortic Valve Presenter: James Dargan October 27, 2024
Presentation TCT 2024 TCT 780: The Influence of Biological Sex on Long-Term Survival Following Transcatheter Aortic Valve Replacement Presenter: James Dargan October 27, 2024
Presentation TCT 2024 TCT 774: Gender Differences in Prevalence, Clinical Presentation, Management Strategies and Clinical Outcomes of Valvular Heart Disease in Hospitalized Patients Presenter: Hiteshi Chauhan October 27, 2024
Presentation TCT 2024 TCT 187: Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis Presenter: Tayyab Shah October 27, 2024
Presentation TCT 2024 TCT 211: Towards Standardizing and Democratizing Mitral Transcatheter Edge-to-Edge Repair With Deep Learning Algorithm Presenter: Quentin Chatelain October 27, 2024
Presentation TCT 2024 TCT 875: A Multicenter Prospective Clinical Study on TAVI With the J-Valve THV for Native Pure Aortic Regurgitation: Five-Year Follow-up Outcome Presenter: Yingqiang Guo October 27, 2024
Presentation TCT 2024 TCT 182: Impact of Heparin-Induced Thrombocytopenia (HIT) on Outcomes in TAVR Patients: A Comprehensive Analysis Presenter: Neethi Dasu October 27, 2024
Presentation TCT 2024 What’s Next for Transcatheter Tricuspid Valve Interventions – Technology and Clinical Research Presenter: D. Scott Lim October 27, 2024
Presentation TCT 2024 Can Future TMVR Systems Fulfill Their Promise in the MR Marketplace? Presenter: Bill Shields October 27, 2024
Presentation TCT 2024 Is Aortic Regurgitation the Next Major TAVR Target? Presenter: Duane Pinto October 27, 2024
Presentation TCT 2024 Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2 Presenter: Ralph von Bardeleben October 27, 2024
Presentation TCT 2024 TCT 859: Impact of Aortic Valve Annular Dimensions Assessment in Various MDCT Systolic Phases on Optimization of Balloon Expandable TAVR Valve Size Selection and Valve Oversizing Percentage Presenter: Denise Mourad October 27, 2024
Presentation TCT 2024 TCT 615: Restenosis, Procedural Success and Long-Term Outcomes After Percutaneous Mitral Balloon Commissurotomy in Rheumatic Mitral Disease: Large Single Center Experience Presenter: Rafael Meneguz-Moreno October 27, 2024
Presentation TCT 2024 TCT 884: TAVR Outcomes in Patients With Cardiogenic Shock: A Systematic Review and Meta-Analysis Presenter: Luai Madanat October 27, 2024
Presentation TCT 2024 Mid-Term Outcomes of Mitral Valve in Valve Therapy in the United States Presenter: Mackram Eleid October 27, 2024
Presentation TCT 2024 TCT 851: Most Patients With Low-Gradient AS Derive Large Improvements in Quality of Life After TAVR Irrespective of Aortic Valve Calcium Score Presenter: Mark Edwards October 27, 2024
Presentation TCT 2024 TCT 614: Clinical Characteristics and Prognosis of Patients With Mitral Annular Calcification Presenter: Gustavo Mendez Hirata October 27, 2024
Presentation TCT 2024 TCT 865: Aortic Root Anatomy Predicts Outcomes After TAVR: Thinking Outside the Box Presenter: KE WEI CHEN October 27, 2024
Presentation TCT 2024 TCT 609: Mortality Trends Due to Non-Rheumatic Valvular Disease Among Adults in the United States From Year 1999-2020: CDC WONDER Database Survey Analysis Presenter: Mobeen Haider October 27, 2024
Presentation TCT 2024 TCT 610: Temporal Trends in Degenerative Mitral Valve Disease-related Mortality in the United States Over the Past 30 Years Presenter: Zaid Abdulelah October 27, 2024